{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:37:35Z","timestamp":1740181055981,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jvacx.2024.100581","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:22:12Z","timestamp":1731000132000},"page":"100581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adverse events following immunization with DTaP-IPV (Tetraxim) in school-aged children in Taiwan, 2017\u20132020"],"prefix":"10.1016","volume":"21","author":[{"given":"Yen-Hsin","family":"Kung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Chang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Camilo","family":"Vargas-Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"WHO. Immunization and vaccine-preventable communicable diseases. WHO website, https:\/\/www.who.int\/data\/gho\/data\/themes\/immunization [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0005"},{"unstructured":"Taiwan CDC. Time schedule of vaccinations. Taiwan CDC website, https:\/\/www.cdc.gov.tw\/Category\/Page\/TxRW-x3WzvPhvEtxM628GA [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0010"},{"unstructured":"Taiwan CDC press release Oct 10 2017. Taiwan CDC website, https:\/\/www.cdc.gov.tw\/Category\/ListContent\/4T8vDeSxOpmz0ILvF_D8Yw?uaid=40MxK_3K72ygwh1LLCKRBg [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0015"},{"unstructured":"European Centre for Disease Prevention and Control. Vaccine schedules in all countries in the EU\/EEA, https:\/\/vaccine- schedule.ecdc.europa.eu\/ [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0020"},{"doi-asserted-by":"crossref","unstructured":"Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 8 Apr 27;67(2):1-44. doi: 10.15585\/mmwr.rr6702a1.","key":"10.1016\/j.jvacx.2024.100581_b0025","DOI":"10.15585\/mmwr.rr6702a1"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100581_b0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40121-022-00650-8","article-title":"Post-marketing surveillance of tetravalent diphtheria-tetanus-acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine in South Korea, 2009 to 2015","volume":"11","author":"Choe","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100581_b0035","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.vaccine.2010.12.094","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100581_b0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14760584.2022.2084076","article-title":"A combined DTaP-IPV vaccine (Tetraxim\u00ae\/Tetravac\u00ae) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience","volume":"21","author":"Huoi","year":"2022","journal-title":"Expert Rev Vaccines"},{"unstructured":"Taiwan CDC. VAERS. https:\/\/www.cdc.gov.tw\/Category\/Page\/3-aXlTBq4ggn5Hg2dveHBg [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0045"},{"unstructured":"Taiwan CDC. Vaccine Injury Compensation Program (VICP) https:\/\/www.cdc.gov.tw\/Uploads\/archives\/4af45ac1-6183-4567-9b5b-eaf625685048.pdf [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0050"},{"unstructured":"Taiwan FDA. Taiwan Act of Adverse Event Reporting definition. http:\/\/www.fda.gov.tw\/tc\/siteContent.aspx?sid=4240 [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0055"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100581_b0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jmii.2019.06.002","article-title":"Resurgence of pertussis in Taiwan during 2009\u20132015 and its impact on infants","volume":"52","author":"Chang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40121-021-00439-1","article-title":"Bordetella pertussis in school-age children, adolescents, and adults: A systematic review of epidemiology, burden, and mortality in Asia","volume":"10","author":"Macina","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jmii.2015.07.006","article-title":"Seroepidemiology of pertussis among elementary school children in northern Taiwan","volume":"50","author":"Kuo","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"unstructured":"Taiwan CDC. Immunization coverage rates. https:\/\/www.cdc.gov.tw\/Category\/MPage\/S2UF2-VuMgfzgzpy7qdvlA [accessed 1 May 2023].","key":"10.1016\/j.jvacx.2024.100581_b0075"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100581_b0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jiab480","article-title":"Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis","volume":"225","author":"Gao","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0085","first-page":"687","article-title":"Long-term immunogenicity assessment of a DTaP-IPV\/\/PRP-T vaccine given at 2, 4, 6 and 18\u201319 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children","volume":"43","author":"Pancharoen","year":"2012","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100581_b0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.vaccine.2016.12.017","article-title":"Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3\u20136years","volume":"35","author":"Southern","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100581_b0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000000475","article-title":"Two cases of extensive limb swelling after influenza vaccination","volume":"34","author":"Cohen","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-018-0059-3","article-title":"Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination","volume":"18","author":"Recher","year":"2018","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100581_b0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jpeds.2010.12.021","article-title":"Extensive limb swelling after vaccination","volume":"158","author":"Huber","year":"2011","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100581_b0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00006454-200208000-00016","article-title":"Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"21","author":"Jackson","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100581_b0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/375820","article-title":"Vaccine adverse event reporting system working group. Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system","volume":"37","author":"Woo","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100581_b0125","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1542\/peds.2005-2890","article-title":"Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children","volume":"118","author":"Marshall","year":"2006","journal-title":"Pediatrics"},{"issue":"32","key":"10.1016\/j.jvacx.2024.100581_b0130","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/S0264-410X(01)00230-4","article-title":"Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens","volume":"19","author":"Scheifele","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100581_b0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1542\/hpeds.2021-005825","article-title":"Utility of inflammatory markers in hospitalized children with skin erythema","volume":"11","author":"Harper","year":"2021","journal-title":"Hosp Pediatr"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:07:25Z","timestamp":1734480445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S2590136224001542"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100581","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following immunization with DTaP-IPV (Tetraxim) in school-aged children in Taiwan, 2017\u20132020","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100581"}}